Venture Capital

A new drug not only reduces osteoarthritis pain significantly but may also be the first to modify the disease itself, a landmark study in The Lancet reveals.

South Korean AI chip leader Rebellions raises $400M, launching full-stack AI systems to redefine efficient inference and spearhead a global expansion.

A $15M grant fuels a revolutionary therapy for a fatal childhood disease, turning patients' own cells into 'living biofactories' to fight MPS I.

Amid a tough biotech market, the firm extends its cash runway to 2027, accelerating development of its promising rademikibart treatment for respiratory diseases.

After a major capital overhaul, PAVmed pivots to growth, advancing cancer diagnostics, remote monitoring, and a relaunched device portfolio.

As millions grapple with Cannabis Use Disorder, a small biotech's lead drug enters Phase 3 trials, promising the first-ever FDA-approved treatment.

Starcloud is now Y Combinator's fastest unicorn. Its audacious plan to build data centers in orbit has attracted top VCs and sparked a new space race for AI.

Magnachip's new power semiconductors promise major efficiency and density gains for servers, tackling the soaring energy needs of the growing AI boom.

At MCE 2026, Midea unveiled a bold new strategy, shifting from products to a full-service ecosystem designed to empower installers and drive a green future.

China's literary giant Yuewen leverages AI and a new generation of creators to build a global IP empire, from novels to AI-dramas and merchandise.

Global CRO ChemPartner launches a new research site in Kent's Discovery Park, a major strategic push to accelerate drug development for European clients.

Highstar launches China's first overseas tabless battery factory in Malaysia, unveiling a high-performance cell for tools, robots, and future eVTOLs.

As Aqua Metals reports its 2025 financials, investors seek proof its recycling tech can deliver amid market volatility and new strategic partnerships.

Digital fabrication giant xTool is sponsoring Austin's Handbuilt Show, bridging the gap between laser precision and old-school motorcycle artistry.

A new challenger enters the ring. The Xtra Atto packs 4K power and a large sensor for $299, but can it truly compete with the giants of the POV camera world?

As elephant Tina faces a life-threatening illness, Samuel L. Jackson pressures the Tulsa Zoo for her and Billy's release to a sanctuary.

Navigator Medicines pushes two novel bispecific antibodies for Hidradenitis Suppurativa, promising better efficacy and patient-friendly dosing.

A federal court sided with Vitti Labs, ruling the FDA's interpretation of tissue rules "plainly erroneous." The decision could reshape the entire industry.

Independent firm FPA is nominated for a top Morningstar award alongside PIMCO and Vanguard, highlighting its rare focus on investor returns over asset size.

Despite citizenship law debates, investor demand for Portugal's Golden Visa remains strong, signaling a strategic shift towards long-term residency.